US20100266989A1 - Teeth whitening compositions and methods - Google Patents

Teeth whitening compositions and methods Download PDF

Info

Publication number
US20100266989A1
US20100266989A1 US12/771,105 US77110510A US2010266989A1 US 20100266989 A1 US20100266989 A1 US 20100266989A1 US 77110510 A US77110510 A US 77110510A US 2010266989 A1 US2010266989 A1 US 2010266989A1
Authority
US
United States
Prior art keywords
composition
tooth
agent
whitening
eosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/771,105
Inventor
Remigio Piergallini
Nikolaos Loupis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KLOX Technologies Inc
Original Assignee
KLOX Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/598,206 priority Critical patent/US8075875B2/en
Application filed by KLOX Technologies Inc filed Critical KLOX Technologies Inc
Priority to US12/771,105 priority patent/US20100266989A1/en
Publication of US20100266989A1 publication Critical patent/US20100266989A1/en
Assigned to KLOX TECHNOLOGIES INC. reassignment KLOX TECHNOLOGIES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LOUPIS, NIKOLAOS, PIERGALLINI, REMIGIO
Priority claimed from AU2015203605A external-priority patent/AU2015203605B2/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/0047Preparations for dentistry characterised by the presence of organic or organo-metallic additives
    • A61K6/0058Dyes
    • A61K6/0061Dyes photochromic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/19Cosmetics or similar toilet preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/19Cosmetics or similar toilet preparations characterised by the composition containing inorganic ingredients
    • A61K8/22Peroxides; Oxygen; Ozone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • A61K2800/434Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Abstract

Disclosed herein are teeth whitening compositions generally including an oxidizing agent (e.g., a peroxide), and an activating agent that has an emission wavelength between about 400 nm and about 570 nm (e.g., Eosin B, Eosin Y, or Erythrosine B). Methods of employing these compositions to whiten teeth, methods of making these compositions and kits that include some or part of the composition ingredients, are also described.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is a continuation-in-part of U.S. patent application Ser. No. 11/598,206 filed on Nov. 9, 2006 and hereby incorporated by reference.
  • FIELD OF THE INVENTION
  • The present invention relates generally to teeth whitening compositions. More specifically, the invention relates to teeth whitening compositions and kits that can be employed to provide a desired whitening effect (e.g., at least two shades of whitening) in less than about 5 minutes of total exposure to actinic light without significant post-treatment sensitivity.
  • BACKGROUND OF THE INVENTION
  • Peroxide and peroxyacid compounds, such as hydrogen peroxide and carbamide peroxide, have been disclosed as useful in teeth whitening compositions. Application of UV or visible light from, e.g., Argon lasers, has been employed to accelerate whitening after application of peroxide compositions to the teeth. Additionally, whitening compositions have been described that include compounds capable of absorbing light and converting it to heat or chemical energy, such as the metal-ligand complexes and metal chelate precursors described in U.S. Pat. No. 6,343,933 to Montgomery et al.
  • Red dyes have also been employed to absorb visible or UV energy and produce heat in a bleaching composition as described, e.g., in U.S. Pat. No. 6,485,709 to Banerjee et al. This patent also describes attempts to further enhance such compositions by adding metal ions, an organo-metallic enzyme (e.g., catalase), or using high pH (e.g., above 7) to destabilize or activate the decomposition of hydrogen peroxide. Teeth whitening compositions have also been described that include violet or blue-violet dyes to counter-stain yellow teeth in U.S. Pat. No. 6,030,222 to Tarver. Rhodamine B dye has been employed in a teeth whitening composition as described in WO 02/22097 to Verheyen et al.
  • Tooth sensitivity following treatment, and the time required for teeth whitening compositions (typically requiring about an hour of time or multiple applications or both), however, remains a significant drawback.
  • SUMMARY OF THE INVENTION
  • The present invention provides novel compositions and methods that whiten teeth in a surprisingly short amount of time (e.g., less than 1 minute to about 10 minutes) and with minimal or no sensitivity post-treatment. The invention is based, in part, on the discovery that the use of the dyes described herein dramatically accelerates the whitening process.
  • Without wishing to be bound to any particular theory, it is believed that inclusion of these dyes significantly enhances the compositions of the invention at least because it is believed that dentin transmits green light and absorbs blue light. Accordingly, the dyes of the present invention enhance whitening not only at the surface of the tooth, but also may be transmitting light into the tooth to enhance the alteration of color agents by radicals that have penetrated into the tooth surface.
  • Another advantage of the present invention is that the compositions can be effective when applied only for a short period of time (e.g., 1 minute in some embodiments). Accordingly, sensitivity due to, e.g., percolation of hydrogen peroxide to the pulp tissue causing (e.g., pulpal inflammation), may be minimized or eliminated. Another advantage of the present invention is that the compositions do not require compounds that generate heat, and therefore, discomfort associated with compositions that generate heat may be minimized or eliminated. Yet another advantage is that dyes can be used (e.g., Eosin) that are less toxic than dyes such as Rhodamine B.
  • In one aspect, the present invention features a tooth whitening composition which includes an oxidizing agent and an activating agent having an emission wavelength between about 400 nm and about 570 nm.
  • In one embodiment, the activating agent is capable of emitting green light, blue light or blue-green light, and/or absorbs green light, blue light or blue-green light. In another embodiment, the activating agent comprises Eosin, Erythrosine, or both.
  • In another embodiment, the composition further includes a stabilizing agent. In one embodiment, the stabilizing agent is sodium acetate.
  • In one embodiment, the composition further includes a thickening agent.
  • In one embodiment, the thickening agent is silicon dioxide and/or fumed silica having a particle size less than one micron.
  • In one embodiment, the composition further includes a hydrophilic gelling agent.
  • In another embodiment, the composition further includes an accelerator agent. In some embodiments, the accelerator agent includes sodium perborate.
  • In one embodiment, the pH of the composition is between about 8 and about 10.
  • The invention also features a method for tooth whitening including applying the tooth whitening composition of the present invention to at least one tooth, and exposing the tooth whitening composition to actinic light such that the tooth is whitened at least about one shade. In one embodiment, the tooth is whitened at least about two shades in less than about 10 minutes or in less than about 5 minutes.
  • In one embodiment, post-treatment sensitivity is insignificant or eliminated.
  • In one embodiment, the tooth is exposed to the tooth whitening composition for less than 5 seconds per application.
  • The invention also features a kit for tooth whitening including a tooth whitening composition of the invention and an apparatus for preparing and/or applying the composition.
  • The invention also features a kit for tooth whitening including a tooth whitening composition of the invention and instructions for determining a composition application time to achieve a desired whitening effect.
  • The invention also features a method for tooth whitening including at least one application of actinic light and a tooth whitening composition to at least one tooth such that the tooth is whitened at least about two shades with less than about 1 minute of total exposure to actinic light. In one embodiment, the tooth is whitened at least about three shades in less than about 30 seconds. In another embodiment, there is no significant post-treatment sensitivity.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates compositions of the present invention compared to other compositions containing other dyes, before and after (see arrows) exposure to actinic light.
  • FIG. 2. illustrates composition of the present invention next to compared to other compositions containing other dyes, after a 5 h period after extrusion of the compositions from a mixing syringe.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • In order to more clearly and concisely describe the subject matter of the claims, the following definitions are intended to provide guidance as to the meaning of specific terms used in the following written description, examples and appended claims.
  • The term “accelerating agent” refers to any agent capable of accelerating and/or contributing to the completion of radical generation (e.g., sodium perborate).
  • The term “actinic light” refers to light energy capable of being absorbed by an activating agent.
  • The term “activating agent” refers to any agent capable of absorbing actinic light. Preferably, the activating agent enhances and/or accelerates the dispersion of light energy, or otherwise enhances and/or activates the decomposition of an oxidizing agent. Activating agents include agents capable of absorbing light energy and emitting light energy, e.g., fluorochromes. Suitable activating agents include. e.g., Eosin, which refers to either Eosin B, Eosin Y, or a combination thereof, and Erythrosine B (also known as Erythrosine).
  • The term “eosin” refers to fluorescent red dye resulting from the action of bromine on fluorescein. There are actually two very closely related compounds commonly referred to as eosin. Eosin Y is a tetrabromo derivative of fluorescein (also known as eosin Y ws, eosin yellowish, Acid Red 87, C.I. 45380, bromoeosine, bromofluoresceic acid, D&C Red No. 22); it has a very slightly yellowish cast. The other eosin compound is eosin B is a dibromo derivative of fluorescein (eosin bluish, Acid Red 91, C.I. 45400, Saffrosine, Eosin Scarlet, or imperial red); it has a very faint bluish cast. The two dyes are interchangeable, and the use of one or the other is a matter of preference and tradition. Thus, Eosin may be eosin B, or eosin Y or a mixture thereof.
  • The term “erythrosine” refers to fluorescent cherry-pink fluorone food coloring. It is the disodium salt of 2,4,5,7-tetraiodofluorescein. It is also known as FD&C Red No. 3, Food Red 14, and Acid Red 51. Erythrosine is also known as erythrosine B.
  • The term “oxidizing agent” refers to any agent capable of oxidizing, and also includes precursors of compounds capable of oxidizing. Examples of oxidizing agents include, but are not limited to, peroxide, peroxy acid, hydrogen peroxide, carbamide peroxide, alkali metal peroxides, alkali metal percarbonates, peroxyacetic acid, and alkali metal perborates.
  • The term “post-treatment sensitivity” refers to sensitivity or instant pain experienced by a subject after a tooth whitening procedure. Sensitivity can include, but is not limited to, stimuli such as temperature and pressure. Instant pain typically occurs without stimuli. The terms “significant sensitivity” or “significant post-treatment sensitivity” and the like, refer to significant discomfort post-treatment, including sensitivity and/or instant pain for more than four hours. The term “insignificant pain” refers to minimum sensitivity to stimuli such as temperature and/or pressure for less than four hours post-treatment.
  • The term “stabilizing agent” refers to any agent that stabilizes one or more agents of the composition (e.g., an oxidizing agent such as hydrogen peroxide). The stabilizing agent can act to stabilize the agent or agents against spontaneous or unwanted reactivity in use and/or in storage. Suitable stabilizing agents include sodium acetate. In some instances, the stabilizing agent can stabilize hydrogen peroxide for about one year.
  • The term “total exposure to actinic light” refers to the total time a tooth is exposed to actinic light including multiple applications of actinic light over the course of a treatment session.
  • The term “transparent” refers to a composition capable of at least 70% transmission of light. The term “translucent” refers to a composition capable of at least about 40% transmission of light. The light referred to can be, e.g., actinic light (e.g., from a laser), emitted light (e.g. from a fluorochrome), or both.
  • The term “translucency agent” refers to any agent capable of increasing the translucency of a composition. Such agents can increase translucency, e.g., upon addition to the composition, upon activation (e.g., by heat, actinic light and/or emitted light), or both.
  • When ranges are disclosed herein (e.g., wavelength, pH, concentration, particle sizes, and whitening ranges) all individual values and ranges within the disclosed ranges are regarded as part of and encompassed by the present invention. All concentrations are provided in weight % of the composition unless indicated otherwise.
  • Where “a”, “an” or the like is used herein, these articles are used in the open or non-restrictive sense, e.g., to indicate “at least one” or “one or more”. Similarly, the term “or” is used in the open or nonrestrictive sense, i.e., to mean “and/or.” Accordingly, the terms “or” and “and/or” are used interchangeably and are meant to have the same meaning.
  • In one aspect, the present invention provides tooth whitening compositions that include an oxidizing agent (e.g., hydrogen peroxide), and an activating agent that has an emission wavelength between about 400 nm and about 570 nm (e.g., Eosin B, Eosin Y, Erythrosine B or combinations thereof). The composition can also include additional agents including, but not limited to, pH adjusting agents, thickening agents, stabilizing agents, accelerating agents, gelling agents, translucency agents.
  • The oxidizing agent can be any oxidizing agent known in the art. In one embodiment, the oxidizing agent includes hydrogen peroxide or sodium perborate or both. Additionally or alternatively, the oxidizing agent can include carbamide peroxide, alkali metal peroxides, alkali metal percarbonates, alkali metal perborates or combinations of these compounds. The oxidizing agents can be, e.g., liquid, gel, or paste compositions capable of interacting with the activating compound when exposed to actinic light.
  • The concentration of the oxidizing agent can be varied in the present invention. In one embodiment, the oxidizing composition includes a hydrogen peroxide, e.g., in a range of about 1% to about 70%. In a further embodiment, the oxidizing composition includes about 50% hydrogen peroxide.
  • The activating agent can include any agent with an emission wavelength between about 400 nm and about 570 nm. In another embodiment, the activating agent emits light in the range of between about 435 nm and about 520 nm. In one embodiment, the activating agent emits light in the range of between about 520 nm and about 565 nm. In certain embodiments, the agent both absorbs and emits light in the above ranges. In one embodiment, the activating agent emits green light. In another embodiment, the activating agent emits blue-green light. In one embodiment the activating agent both absorbs and emits green light.
  • In one embodiment, the activating agent includes at least one of Eosin B, Eosin Y, or Erythrosine B or combinations thereof. In another embodiment, the whitening composition includes in the range of about 0.5% to about 0.8%, or between about 0.02% and about 1.2% or less than about 12% of at least one of Eosin B or Eosin Y or combinations thereof, or from about 0.02% to about 12% of at least one of Eosin B or Eosin Y or combinations thereof. In yet another embodiment, the composition includes about 0.02% to about 12% of Eosin B or Eosin Y or combinations thereof, and/or from about 0.01% to about 1%, or about 0.005% and about 0.15%, or from about 0.005% to 1% of Erythrosine B. It is believed that the combination of Eosin B and/or Eosin Y and/or Erythrosine B has a synergistic effect. It is believed this synergistic effect may be related to the close absorption peaks of the dyes. It is further believed that because Eosin B and/or Eosin Y and Erythrosine B reemit green light, that this green light can and may be further absorbed (or reabsorbed) by the fluorochromes so that light energy is not dissipated as in conventional compositions. This absorbed and re-emitted light not only penetrates throughout the bleaching gel, but also is transmitted into the enamel and dentin. Dyes such as Eosin B and Eosin Y are also advantageous as they are significantly less toxic than dyes such as Rhodamine B.
  • Without wishing to be bound to any particular theory, it is believed that because dentin and enamel transmit green light, light in this range can be transmitted into the dentin and/or enamel of the tooth, causing excitation of electrons in specific chemical bonds within the activating agent and tooth chromophores, making them more susceptible to be attacked by free radicals. The activating agents of the invention can include blue-green and/or blue emitting dyes. Accordingly, the present invention is based, at least in part, on the discovery that the use of the activating agents of the invention significantly enhance and/or contribute to the enhancement of a whitening effect in a fraction of the time required by conventional compositions. Because the teeth are only exposed to the whitening composition for a fraction of the time as compared to conventional teeth whitening compositions, superficial cracks and crevices, caused by prolonged exposure to free radicals, can be reduced or eliminated. Because decalcification can occur in the cracks and crevices caused by prolonged exposure to free radicals, stains more easily return as the decalcified enamel acts as a sponge. In the present invention, the decreased exposure time to free radicals reduces the possibility of crevices and cracks, thus leading to a significantly prolonged or permanent whitening effect for deeper pigments. Moreover, prolonged periods of exposure cause the enamel to become brittle. It is believed that the composition and methods of the present invention avoid compromise of the enamel.
  • In one embodiment, the activating agent or agents not only are capable of emitting light in the wavelength range from about 400 nm to about 570 nm, but also absorb light in the wavelength range from about 400 nm to about 570 nm. Such an activating agent is activated by light in the wavelength range of from about 400 nm to about 570 nm. Accordingly, in one embodiment the activating agent absorbs light in the wavelength range of about 400 nm to about 570 nm. In another embodiment, the activating agent absorbs light at a wavelength between about 470 nm to about 550 nm. This embodiment therefore allows for the optimal absorption of energy from the actinic light and the optimal transmission through dentin and enamel.
  • Without wishing to be bound to any particular theory, it is also believed that activating agents of the present invention, when exposed to actinic light, can accelerate the dispersion of light energy which consequently leads to an instantaneous and complete photochemical activation of the peroxide within the gel. It is believed that the gel mass better transmits light in the wavelength range of about 400 nm to about 570 nm, so that when an activating agent is exposed to actinic light, the dispersion of the light energy leads to an accelerated photochemical activation of the peroxide. Together, these embodiments allow for optimal absorption by the activating agent of energy from the actinic light and the optimal transmission through the composition, dentin and enamel.
  • In one embodiment, the composition also includes a stabilizing agent. In one embodiment, the stabilizing agent stabilizes the peroxide concentration in the composition for days, weeks, months, a year or several years. In one embodiment, the stabilizing agent not only stabilizes the oxidizing agent, but also is a pH modifier and/or stabilizer. In another embodiment, the stabilizing agent is sodium acetate. In one embodiment, sodium acetate is added until the desired pH is attained. In yet another embodiment, the composition includes between about 0.1% and about 50% stabilizing agent. Any value or range within this range is meant to be encompassed.
  • In one embodiment, the stabilizing agent is selected from the group consisting of antioxidants such as sodium sulfite, metal chelators (e.g., EDTA), and stabilizers (e.g., tin salts, phosphoric acid, and tin sulphonates). In some embodiments, the stabilizing agent scavenges or otherwise isolates or removes from solution, metal ions that can potentially destabilize the hydrogen peroxide.
  • In one embodiment, the stabilizing agent is or includes sodium acetate (e.g., sodium acetate trihydrate). Sodium acetate has been found to inhibit spontaneous reactivity of hydrogen peroxide and therefore can provide improved stability.
  • In one embodiment, the pH of the composition is in or adjusted to the range of from about 4 to about 10. In alkaline conditions, with a pH from about 8 to about 10, the stronger free radical, perhydroxyl ions, can be generated. Perhydroxyl free radicals are capable of reacting not only with yellow and brown stains but even with grey chromophores situated deeper in the tooth structure. In further embodiments, the pH of the composition is between about 5 and about 7, or between about 5 and about 6. In certain embodiments the pH is about 6.
  • Suitable pH adjusting agents include, but are not limited to, sodium hydroxide, potassium hydroxide, ammonium hydroxide, sodium carbonate, potassium carbonate, TRIS, and triethanolamine, or any other salt of an alkaline base which is safely used in the mouth. In another embodiment, the pH adjusting agent is sodium perborate. In certain embodiments of the invention, a single component may act as a pH adjusting agent or as a stabilizing agent or may serve both functions. In one embodiment, sodium acetate acts as a pH adjusting agent and as a stabilizing agent. In further embodiments, the pH adjusting agent is of the group consisting of sodium bicarbonate, calcium bicarbonate, sodium carbonate and calcium carbonate.
  • Additionally or alternatively, the composition can include a thickening agent to improve the ease of application of the composition to the teeth such that even and effective coverage is more readily achieved. Suitable thickening agents include but are not limited to mixed silica-aluminum oxides, long chain hydrocarbons such as synthetic carbomers (e.g., Carbopol), triethanolamine (e.g., Trolamine), and water soluble poly (ethylene oxide) resins (e.g., Polyox™). Suitable thickening agents also include amide starches.
  • It has been found that using an agent which has a particle size in the range from about 0.2 microns (μm) to about 0.7 μm provides for more widespread dispersion of the oxidizing agent on the particle surface. Accordingly, in one embodiment, the activating agent has a particle size below about 2 microns or below about 1 micron. In other embodiments, the agent has a particle size below about 0.8, 0.7, 0.6, 0.5, 0.4, 0.3, or 0.2 microns. In other embodiments, the activating agent has a particle size between about 0.1 and about 0.8, between about 0.2 and about 0.7, or between about 0.3 and about 0.6 microns.
  • Additionally or alternatively, the thickening agent can include fumed silica and/or any other inert inorganic material that may be used as a carrier and can aid in the delivery of active oxygen to the tooth surface. Fumed silica of a small particle size (e.g., between about 0.2 microns and about 0.4 microns), can provide efficient dispersion of hydrogen peroxide and reflection of light energy within the oxidizing composition.
  • In some embodiments, the compositions of the invention include a reaction accelerator or accelerating agent. In one embodiment, the composition includes sodium perborate. Sodium perborate has selective reactivity with hydrogen peroxide in forming free radicals (reacts with water to release hydrogen peroxide). The use of one or more activating agents (e.g., sodium perborate) can be advantageous because they can absorb and retain heat generated in the composition by, e.g., actinic light, thus restricting any such heat to the gel in order to accelerate the reaction without heating the tooth, which can cause sensitivity. In addition, acceleration of the reaction means that the composition can be removed more quickly than conventional compositions thereby decreasing exposure of the patient to the composition and resulting sensitivity and/or other damage to tissues and teeth.
  • In one embodiment, the compositions of the invention include between about 0.8% and about 15%, or between about 0.3% and about 18% accelerator agent.
  • In further embodiments, the compositions of the invention include a gelling agent. Preferably the gelling agent is also a translucency agent. For example, a hydrophilic gelling agent can be employed to increase the translucency of the resulting composition or gel.
  • In some embodiments, the nature of the gelling agent (e.g., its hydrophilic nature) prevents vaporization of the gel when exposed to actinic light, thus improving hydration of the coated tooth area. Increased hydration of the teeth and surrounding tissues is associated with decreased discomfort and sensitivity. In one embodiment, the gelling agent can include, for example, one or more modified starches and/or glucose. In one embodiment, modified starches and/or glucose are activated in cold water. In some embodiments, the gelling agent further enhances the consistency of the composition, facilitating the application to the tooth surface.
  • The translucency agent can enhance translucency or transparency upon addition to the composition and/or upon activation by, e.g., actinic light, emitted light and/or heat. In one embodiment, it minimizes vaporization of the composition. Additionally or alternatively, the gelling and/or translucency agent minimizes any thermal effects by absorbing any heat generated in the composition.
  • In one embodiment the composition is a translucent composition. In another embodiment the composition is a transparent composition. In certain embodiments, the composition is translucent or transparent to the actinic light it will be exposed to e.g., green, blue-green or blue light).
  • In one embodiment, the composition includes an oxidizing agent (e.g., hydrogen peroxide), an accelerating agent (e.g., sodium perborate), an activating agent (Eosin B, Eosin Y, Erythrosine B or combinations thereof), a stabilizing agent (e.g., sodium acetate trihydrate), a pH adjusting agent, a thickening agent (e.g., fumed silica or silicon dioxide or both), and a gelling agent. In one embodiment, the pH of the composition is from about 6 to about 10. In some embodiments, the pH of the composition is from about 8 to about 10. In other embodiments, the pH of the composition is from about 4 to about 10.
  • Another aspect of the invention provides a method for tooth whitening including applying a tooth whitening composition of the present invention to at least one tooth, and exposing the tooth whitening composition to actinic light to activate the oxidizing agent. The composition may be any of the compositions described herein.
  • In one embodiment, the method for bleaching the teeth is performed in a dentist's office or dental operatory under ordinary conditions. The composition can be mixed chair-side and applied to the surfaces of as many teeth as are desired to be whitened. Alternatively, the composition can be provided without the need for mixing chair-side. Thereafter, the composition can be exposed to actinic light to accelerate decomposition of the oxidizing agent and the formation of free radicals. In one embodiment, premixes can be prepared with some or all of the ingredients and then mixed chairside and applied to the teeth. In one embodiment, a hydrogen peroxide/sodium acetate solution premix can be prepared and stored prior to use. Additionally or alternatively, some or all of the remaining ingredients can also be separately premixed and stored prior to use. Such premixes can be stored, e.g., for at least about one year.
  • The compositions of the invention can be used to whiten teeth discolored by any agent or disorder. For example, the compositions may be used to whiten discoloration due to stains (e.g., tobacco, coffee, tea and/or food stains), fluorosis, developmental disturbances, bacteria, genetics, tetracycline antibiotics, trauma, blood decomposition, pigments present during development of teeth, etc.
  • Any source of actinic light can be used and preferably it is capable of emitting light in a wavelength appropriate to the activating agent employed in the composition. In one embodiment, e.g., an argon laser is used. In another embodiment, a potassium-Titanyl phosphate (KTP) laser (e.g., a GreenLight™ laser) is used as a light source. In one embodiment the light source emits light at or near the absorption wavelength of the activating agent or at least one of the activating agents, if several are included in the composition.
  • The most intense fluorescence (e.g., emission) from a fluorochrome dye occurs when it is irradiated with wavelengths close to the peak of the absorption wavelength (i.e., excitation curve). Accordingly, in one embodiment, the actinic light is at a wavelength of about the absorption wavelength of the activating agent. In one embodiment, the actinic light has a wavelength in the range from about 470 nm to about 550 nm. In another embodiment, the actinic light has a wavelength in the range from about 470 nm to about 520 nm. In yet another embodiment, an argon laser provides actinic light in the wavelength range from about 470 nm to about 520 nm. In a further embodiment, the actinic light has a wavelength of about 530 nm to about 535 nm. In still another embodiment, the source of actinic light in the wavelength range of about 530 nm to about 535 nm is a KTP laser. In this embodiment the source is a KTP laser set at about 532 nm. In another embodiment, a photocuring device is the source of actinic light.
  • In one embodiment, the tooth is exposed to actinic light for less than 20 minutes, in another for less than 10 minutes, in another for less than 5 minutes. In one embodiment the tooth is exposed to actinic light for less than 4, 3, 2, or 1 minute. In one embodiment, the invention provides a method for whitening teeth at least 2 shades in about 1 minute. In some embodiments, there is no significant post-treatment sensitivity. In other embodiments, there is no post-treatment sensitivity.
  • In one embodiment, the tooth whitening composition is applied and the tooth is exposed to multiple applications of actinic light, for a time of about 4 to about 6 seconds each tooth per exposure. In some embodiments, the tooth is exposed to actinic light at least two, three, four, five or six times. In some embodiments, a fresh application of the tooth whitening composition is applied before each exposure to actinic light. In some embodiments, the total exposure to actinic light is less than about one minute. In other embodiments, the total exposure to actinic light is less than about 60, 40, 30, or 20 seconds.
  • In one embodiment, the tooth is whitened at least 7 shades, 6 shades, 5 shades, 4 shades, 3 shades, 2 shades or 1 shade. Shades can be determined before and after treatment using any of a number of shade guides, including, e.g., the VITA® (Vita Zahnfabrik H. Rauter GmbH & Co., KG), CHROMASCOP® (Ivoclar Vivadent, Inc.) or BIODENT (Dentsply Intenational) shade guides. Optionally, a shade taking system, e.g., the ShadeEye NCC Dental Chroma Meter, can be employed to determine shade before and/or after treatment.
  • In one embodiment, the tooth is whitened at least two shades, three shades, four shades, five shades, six shades or seven shades in less than about one minute of total exposure time to actinic light. In some embodiments, the tooth is whitened at least two shades, three shades, four shades, five shades, six shades or seven shades in less than about 40 seconds of total exposure time to actinic light. In some embodiments, the tooth is whitened at least two shades, three shades, four shades, five shades, six shades or seven shades in less than about 30 seconds of total exposure time to actinic light. In some embodiments, the tooth is whitened at least two shades, three shades, four shades, five shades, six shades or seven shades in less than about 20 seconds or even less than about 10 seconds of total exposure time to actinic light.
  • In one embodiment, the risk of transient inflammation of the pulp by percolation of hydrogen peroxide is reduced, not significant and/or eliminated. Without wishing to be bound by any particular theory, inflammation of the pulp is thought to be caused by percolation of hydrogen peroxide into the pulp tissue. In some embodiments, the synergistic effect of the activating agents (e.g., Eosin B and/or Eosin Y and/or Erythrosine B), and the actinic light results in an instantaneous and complete photochemical reaction. Accordingly, exposure of the tooth, the pulp, and/or the surrounding tissues to the oxidizing agent and/or other components in the composition is dramatically reduced.
  • In yet another aspect, the invention provides a method for tooth whitening comprising application of actinic light and a composition of the invention (any of the compositions described herein) to at least one tooth such that the tooth is whitened at least about two shades in less than about 10 minutes. In another embodiment, the tooth is whitened at least about two shades in less than about 5 minutes, less than about 4 minutes, less than about 3 minutes, less than about 2 minutes or in about 1 minute. In some embodiments, the teeth are whitened at least about 3 shades, 4 shade or 5 shades. In some embodiments, there is no significant post-treatment sensitivity or no post-treatment sensitivity.
  • In yet another aspect, the invention provides a kit for preparing or applying a tooth whitening composition in accordance with the present invention. In one embodiment, the kit includes an oxidizing agent and an activating agent that has an emission wavelength between about 400 nm and about 570 nm. The composition can be any of the compositions of the present invention. In one embodiment, the composition is not combined, and may optionally include apparatus to combine two or more components or premixes of the composition. In another embodiment the composition does not require any combination (i.e., it is ready to use and does not require any pre-mixing chair-side).
  • In another embodiment, the kit includes a composition of the invention and directions for application. Additionally or alternatively, the kit can include apparatus for application (e.g., brushes or trays or both). The kit can also include charts or other information helpful in assessing the whitening effect desired and/or achieved by the methods and compositions of the invention. The kit can also include a source of actinic light.
  • Identification of equivalent compositions, methods and kits are well within the skill of the ordinary practitioner and would require no more than routine experimentation, in light of the teachings of the present disclosure. Practice of the invention will be still more fully understood from the following examples, which are presented herein for illustration only and should not be construed as limiting the invention in any way.
  • Example 1 Preparation of an Exemplary Whitening Composition and Activation by Actinic Light
  • A premix was prepared by mixing 4 mg of Eosin B, 1 mg Erythrosine B, 450 mg fumed silica, and 45 mg sodium perborate. Separately, the pH of a 50% hydrogen peroxide solution was adjusted to pH 6 using sodium acetate solution. Approximately 4-6 ml of the adjusted hydrogen peroxide solution was then added to the premix in a plastic mixing chamber and immediately applied.
  • The gel was applied to frontal surface of the teeth of each subject beginning from the frontal anterior incisors, followed by the posteriors, and finally the posterior incisors. The gel was activated by a KTP laser set at a continuous wave of 0.5 watts. The laser was applied to each tooth for 2-3 seconds. During this time, the gel turned from orange-red to transparent and eventually became dull. After 3-4 minutes for two full arches from premolar to premolar, the gel was aspirated, and the teeth were lightly scrubbed with a cotton roll to clean the surface of the enamel. A second coating of gel was applied using fresh gel and activated with the KTP laser as described above. Up to six consecutive applications were performed to achieve the desired whitening effect for each patient. The duration of the sessions typically did not exceed 40 minutes.
  • Example 2 Whitening Effect of Composition
  • A comparative study was conducted on 10 volunteers between an exemplary composition of the present invention and the SMARTBLEACH laser teeth whitening systems, which is a composition comprising Rhodamine B and hydrogen peroxide. The shade of each patient's teeth was recorded prior to application of whitening composition.
  • Teeth were coated with the composition prepared in Example 1 and exposed to actinic light from a green laser set at 532 nm for one minute for the entire mouth (4-5 seconds per tooth) and then the composition was removed. The comparative composition was applied to the teeth and exposed to light from a green laser set at 532 nm for 30 seconds per tooth and then left on the surface of the tooth for 10 minutes, in accordance with the manufacturer instructions provided with the composition. The comparative composition required at least 3 to 4 applications, for a total duration of about 1.5 hours for the entire mouth. The composition was removed from each volunteer and the teeth were irrigated with water. The teeth were then evaluated using the VITA scale for the whitening effect of the compositions. Patients were also evaluated for any post-treatment sensitivity by asking them to rate the level of pain experience if any.
  • The Smartbleach™ treatment resulted in a shade change of one to two shades in the yellow group, while the exemplary composition of the present invention resulted in a shade change of 5 shades in the yellow group, e.g., A4 to B1 VITA scale. In the “yellow group”(A4-A1), treatment with the exemplary composition of the present invention resulted in shade changes of 4-5 shades, resulting in shades in the “white group” (B1-B2). Treatment with the exemplary composition for teeth in the “grey” (C4-C1) and “grey-brown” (D4-D2) groups showed changes of 2-3 shades in the first session.
  • The following evaluation scale of post-sensitivity was used:
  • Level 0 No sensitivity to thermal stimuli or any kind of pain following
    treatment.
    Level 1 Sensitivity to thermal stimuli that lasts for a few seconds.
    Level 2 Pain or discomfort that occurs due to thermal stimuli and
    lasts for more than one minute. Optional pain treatment
    with analgesics.
    Level 3 Pain or discomfort that occurs automatically, requiring use of
    analgesics to control the pain.
  • Following treatment with the Smartbleach™ system, all ten subjects experienced pain from Level 1 to Level 3. Following treatment with the exemplary composition of the present invention, nine subjects experienced no pain (e.g., Level 0), and only one subject experienced pain of Level 1.
  • Example 3 Effect of Actinic Light Source
  • A study was conducted on 28 volunteers comparing the effect of different actinic light sources in whitening with the composition of Example 1. A prophylactic session was performed on each patient 3-4 days before the bleaching session. The shade of each patient's teeth was recorded prior to application of whitening composition.
  • Teeth were coated with the composition prepared in Example 1 and exposed to different sources of actinic light: a green laser (KTP) at 532 nm, a blue (argon) laser at 480-414 nm, a photo curing halogen lamp, and a LED photocuring device. The activation was performed in the different patients for the left or the right sides of their dental arches according to an activation randomization mode. Specifically, a first patient's right side was activated with the 532 nm green laser, while the left side was activated with the 480 nm-514 nm blue-green laser. A second patient's right side was activated with the photocuring halogen lamp, while the left side was activated with the LED photo curing device. A third patient's right side was activated with the 532 nm green laser, while the left side was activated with the photocuring halogen lamp. A fourth patient's right side was activated with the 532 nm green laser, while the left side was activated with the LED photocuring device. A fifth patient's right side was activated with the 480 nm-514 nm blue-green laser, while the left side was activated with the photocuring halogen lamp. A sixth patient's right side was activated with the 480 nm-514 nm blue-green laser, while the left side was activated with the LED photocuring device.
  • The composition was removed from the teeth of each volunteer and the teeth were irrigated with water. The teeth were then evaluated using the VITA scale for the whitening effect of the compositions.
  • Activation by different photo curing devices produced comparable results. The speed of activation with the green laser and the blue-green laser was 4-5 seconds per tooth, while the speed of activation with the photo curing devices was about 10 seconds per tooth. Accordingly, a whitening session employing the green laser or the blue-green laser for the entire mouth would typically take approximately 30 minutes, and a session with a photocuring device would typically take approximately 40 minutes.
  • Example 4 Preparation of Composition
  • Teeth whitening compositions were prepared according to the following table:
  • TABLE 1
    Description Present Invention Prior art
    Activating 1. Eosin Y (0.7 mg/g) 4. Acid Red 388 (0.7 mg/g)
    agent 2. Erythrosine B (0.7 mg/g) 5. Acid Red 92 (0.7 mg/g)
    3. Eosin Y & Erythrosine B 6. Acid Red 388 & Acid Red
    (both 0.7 mg/g) 92 (both 0.7 mg/g)
    7. FD&C Red 40 (0.7 mg/g)
    Common Hydrogen peroxide
    components Silica
    (Photoactive Starch
    booster) Sodium perborate
    Sodium Acetate
    Distilled water
  • Example 5 Clinical Assessment of Light Absorption and Quantitative Measurement of Fluorescence Emission
  • Samples of each teeth whitening composition were extruded from a syringe after mixing, and a portion of each extruded sample was exposed to actinic light for 60 seconds, while the remainder was not. Visual assessment of the change in color was performed and a photograph of the composition was taken immediately after light exposure.
  • Now referring to FIG. 1. Prior to exposure to actinic light, all compositions displayed a clear and distinct coloring according to the dye used in the composition. During exposure to actinic light, the compositions of the present invention markedly fluoresced, as did the compositions containing the Acid Red dyes, but the composition containing FD&C Red 40 appeared non-fluorescent (results not shown). Following actinic light exposure, the coloring of the compositions of the present invention distinctly changed: the composition containing eosin Y alone turned a pristine white, while the composition containing erythrosine B and eosin Y+erythrosine B turned a bluish color. The compositions containing Acid Red 388 or Acid Red 92 alone, or a mixture of these two dyes did not change color. Lastly the compositions containing FD&C Red 40 was also unchanged. Thus, only the compositions of the present invention displayed any robust photochemical bleaching reactions.
  • Now referring to FIG. 2. Following actinic light exposure, all three of the compositions of the present invention became soft and moist, and collapsed into single mass of composition. The addition of sodium acetate to the gel composition accelerated the activation of the gel when exposed to actinic light. This acceleration may be caused by the increase in pH of the photoactive booster. Gas bubbles were observed emerging from the samples. This observation is consistent with a rapid and robust decomposition of hydrogen peroxide into water and oxygen (as per the known reaction: 2H2O2→2H2O+O2) accelerated by the dispersion of light energy in the composition by the activating agents. All the other sample compositions did not mix into a single mass, but rather preserved a more solid texture, with a strand-like aspects, as generated during extrusion from the syringe. As shown in FIG. 2, a second visual assessment was performed after the compositions had been left unattended for 5 hours at room temperature. Interestingly, the compositions of the present invention remained moist and showed evidence of gaseous releases, while the other compositions had hardened after this period. These results suggest that the compositions of the present invention are able to effect an accelerated photochemical activation of the hydrogen peroxide present in the composition. None of the other tested compositions displayed comparable results.
  • Example 6 Teeth Whitening Results
  • Composition containing eosin Y and erythrosine B and compositions containing Acid Red 388, Acid Red 92 alone or in combination, and FD&C Red 40 were prepared as above. Each of the sample composition was directly and simultaneously tested on the teeth of a human subject. The mouth of each subject was divided in 4 quadrants (upper-left, lower-left, upper-right, and lower-right). To maintain a fixed optical position to assess teeth whitening, the composition of the present invention was in each case applied to the right quadrants, while the comparative composition was applied to the left quadrants. The compositions were exposed to actinic light (a Blue Phase LED photo curing device) for 20 seconds per tooth. The effect of each composition was scored according to the Vita® Brightness scale.
  • TABLE 2
    Comparative results of teeth whitening using the
    composition of the present invention and compositions
    containing Acid Red dyes or FD&C Red 40
    Vita shade Vita shade
    Patient Right quadrant conversion Left quadrant conversion
    1 Eosin Y and A3 to A1 Acid Red 388 A3 to A2.5
    Erythrosine B (7shades) (>3 shades)
    2 Eosin Y and A3 to A1 Acid Red 92 No change
    Erythrosine B (7shades)
    3 Eosin Y and A3 to A1 FD&C Red 40 No change
    Erythrosine B (7shades)
    Vita ® Brightness scale B1 = lightest shade C4 = darkest shade
    B1 A1 B2 D2 A2 C1 C2 D4 A3
    1 2 3 4 5 6 7 8 9
    Vita ® Brightness scale B1 = lightest shade C4 = darkest shade
    D3 B3 A3.5 B4 C3 A4 C4
    10 11 12 13 14 15 16
  • For each of the three patients treated, use of the composition of the present invention resulted in a significant improvement of 7 shades (A3 to A1), while the composition containing Acid Red 388 caused a modest improvement slightly better than 3 shades (A3 to A2.5). Compositions containing Acid Red 92 or FD&C Red 40 had no effect whatsoever. Thus, the composition of the present invention is the most efficient teeth whitening composition.
  • The scientific results above show that based on exposure to actinic light, the red dyes used in the composition of the present invention are more readily activated. Also, these scientific results show that under the teeth whitening conditions of 20 seconds per teeth, use of either Acid Red 388, Acid Red 92, or FD&C Red 40 do not result in a teeth whitening effect as potent as that of the composition of the present invention. In fact, Acid red 92 and FD&C Red 40 are unable to effect any teeth whitening effect under the conditions used. These results indicate that these dyes do not contribute as efficiently (if at all) as eosin Y or erythrosine B, to a teeth whitening effect.
  • Example 7 Teeth Whitening Results
  • Compositions containing eosin Y alone, erythrosine B alone, both eosin Y and erythrosine B, and compositions containing Acid Red 388, Acid Red 92 alone or in combination, and FD&C Red 40 were prepared as Example 5 above. Each of the sample composition was directly tested on the teeth of a human subject. The compositions were exposed to actinic light (a Blue Phase LED photo curing device) for 20 seconds per tooth. The effect of each composition was scored according to the Vita® Brightness scale.
  • TABLE 3
    Comparative results of teeth whitening using the
    composition of the present invention and compositions
    containing Acid Red dyes or FD&C Red 40
    Patient Dyes Vita ® shade conversion
    1 Eosin Y and erythrosine B A3 to A1
    (7 shades)
    2 Eosin Y alone A3 to A1
    (7 shades)
    3 Erythrosine B alone A3 to C2
    (2 shades)
    4 Acid Red 388 A3 to A2
    (4 shades)
    5 Acid Red 92 No change
    6 FD&C Red 40 No change
    7 Acid Red 388 and Acid Red 92 A3 to A2
    (4 shades)
    Vita ® Brightness scale B1 = lightest shade C4 = darkest shade
    B1 A1 B2 D2 A2 C1 C2 D4 A3
    1 2 3 4 5 6 7 8 9
    Vita ® Brightness scale B1 = lightest shade C4 = darkest shade
    D3 B3 A3.5 B4 C3 A4 C4
    10 11 12 13 14 15 16
  • For each of the three patients treated, use of the composition of the present invention containing eosin Y alone or eosin Y and erythrosine B resulted in a significant improvement of 7 shades (A3 to A1), while the composition containing Acid Red 388 alone or in combination with acid red 92 caused a modest improvement slightly better than 3 to 4 shades (A3 to A2.5 or A2). Compositions containing Acid Red 92 alone or FD&C Red 40 alone had no effect whatsoever. Thus, the composition of the present invention is the most efficient teeth whitening composition.
  • The scientific results above show that based on exposure to actinic light, the red dyes used in the composition of the present invention are more readily activated. Also, these scientific results show that under the teeth whitening conditions of 20 seconds per teeth, use of either Acid Red 388, Acid Red 92, or FD&C Red 40 do not result in a teeth whitening effect as potent as that of the composition of the present invention. In fact, Acid red 92 and FD&C Red 40 are unable to effect any teeth whitening effect under the conditions used. These results indicate that these dyes do not contribute as efficiently (if at all) as eosin Y or erythrosine B, to a teeth whitening effect.

Claims (24)

1. A tooth whitening composition for whitening a tooth in vivo in the gingiva of a patient, the tooth whitening composition comprising:
an oxidizing agent;
an activating agent having an emission wavelength between about 400 nm and about 570 nm and capable of activating said oxidizing agent, said activating agent consisting of Eosin, Erythrosine, or a combination of Eosin and Erythrosine; and
sodium acetate, sodium perborate or both.
2. The composition according to claim 1, wherein the activating agent is Eosin.
3. The composition according to claim 1, wherein the composition comprises a thickening agent.
4. The composition according to claim 3, wherein the thickening agent is silicon dioxide and/or fumed silica having a particle size less than one micron.
5. The composition according to claim 1, wherein the composition comprises a hydrophilic gelling agent.
6. The composition according to claim 1, wherein the pH of the composition is between about 4 and about 10.
7. A method for whitening a tooth in vivo in the gingiva of a patient, the method for tooth whitening consisting of:
applying to at least one tooth a tooth whitening composition comprising:
an oxidizing agent; and
an activating agent having an emission wavelength between about 400 nm and about 570 nm and activating said oxidizing agent, said activating agent consisting of Eosin, Erythrosine, or a combination of Eosin and Erythrosine; and
exposing the tooth whitening composition to actinic light for a period between 5 seconds and 10 minutes.
8. The method according to claim 7, wherein the tooth is exposed to light for a period between 5 minutes and 10 minutes.
9. The method according to claim 7, wherein the tooth is exposed to the tooth whitening composition for less than 5 seconds per application.
10. The method according to claim 7, wherein the tooth is exposed to light for a period of 1 minute.
11. The method according to claim 7, wherein the tooth is exposed to light for a period of 30 seconds.
12. A method for whitening a tooth in vivo in the gingiva of a patient, the method for tooth whitening consisting of:
applying to at least one tooth a tooth whitening composition comprising:
an oxidizing agent; and
an activating agent having an emission wavelength between about 400 nm and about 570 nm and activating said oxidizing agent, said activating agent consisting of Eosin, or Eosin and Erythrosine; and
exposing the tooth whitening composition to actinic light for a period between 5 seconds and 10 minutes.
13. The method according to claim 12, wherein the tooth is exposed to light for a period between 5 minutes and 10 minutes.
14. The method according to claim 12, wherein the tooth is exposed to the tooth whitening composition for less than 5 seconds per application.
15. The method according to claim 12, wherein the tooth is exposed to light for a period of 1 minute.
16. The method according to claim 12, wherein the tooth is exposed to light for a period of 30 seconds.
17. A kit for tooth whitening comprising:
a composition according to claim 1; and
an apparatus for applying the composition.
18. A kit for tooth whitening comprising:
a composition according to claim 1; and
instructions for determining a composition application time to achieve a whitening effect.
19. A tooth whitening composition for whitening a tooth in vivo in the gingiva of a patient, the tooth whitening composition comprising:
an oxidizing agent;
an activating agent having an emission wavelength between about 400 nm and about 570 nm and capable of activating said oxidizing agent, said activating agent consisting of Eosin, Erythrosine, or a combination of Eosin and Erythrosine;
sodium acetate;
a thickening agent;
a hydrophilic gelling agent; and
sodium perborate.
20. The tooth whitening composition according to claim 19, wherein the activating agent is Eosin.
21. The composition of claim 19, wherein the thickening agent is silicon dioxide and/or fumed silica having a particle size less than one micron.
22. The composition of claim 19, wherein the pH of the composition is between about 4 and about 10.
23. A kit for tooth whitening comprising:
a composition according to claim 19; and
an apparatus for applying the composition.
24. A kit for tooth whitening comprising:
a composition according to claim 19; and
instructions for determining a composition application time to achieve a whitening effect.
US12/771,105 2005-11-09 2010-04-30 Teeth whitening compositions and methods Abandoned US20100266989A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/598,206 US8075875B2 (en) 2005-11-09 2006-11-09 Teeth whitening composition and methods
US12/771,105 US20100266989A1 (en) 2006-11-09 2010-04-30 Teeth whitening compositions and methods

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US12/771,105 US20100266989A1 (en) 2006-11-09 2010-04-30 Teeth whitening compositions and methods
CN2011800300104A CN102939072A (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
NZ631120A NZ631120A (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
NZ603601A NZ603601A (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
SG2012077665A SG184945A1 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
JP2013506427A JP6061342B2 (en) 2010-04-30 2011-04-29 Whitening method of photoexcited oxygen release compositions and teeth
EA201291068A EA030336B1 (en) 2010-04-30 2011-04-29 Use of a photoactivatable composition for whitening a tooth and method for whitening a tooth using same
SG10201503416UA SG10201503416UA (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
PCT/CA2011/050261 WO2011134087A1 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
AU2011245008A AU2011245008A1 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
KR1020127031383A KR101869109B1 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
BR112012027538-0A BR112012027538B1 (en) 2010-04-30 2011-04-29 Composition, use of the composition, a method for whitening a tooth in vivo gums of a patient for dental bleaching kit and the use of the kit
CA2797867A CA2797867C (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
EP16200524.3A EP3202391A1 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
MX2012012481A MX343075B (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening.
US13/643,672 US9345648B2 (en) 2006-11-09 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
EP11774256.9A EP2563323A4 (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
CN201610944578.1A CN107049818A (en) 2010-04-30 2011-04-29 Photoactivatable oxygen-evolving compositions and methods
IL222526A IL222526D0 (en) 2010-04-30 2012-10-18 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
ZA2012/08990A ZA201208990B (en) 2010-04-30 2012-11-28 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
AU2015203605A AU2015203605B2 (en) 2010-04-30 2015-06-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
JP2015222108A JP2016065077A (en) 2010-04-30 2015-11-12 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US15/133,536 US20160296444A1 (en) 2006-11-09 2016-04-20 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
AU2017203653A AU2017203653A1 (en) 2010-04-30 2017-05-31 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
JP2017230534A JP2018065844A (en) 2010-04-30 2017-11-30 Photoactivatable oxygen-evolving compositions and methods for teeth whitening

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/598,206 Continuation-In-Part US8075875B2 (en) 2005-11-09 2006-11-09 Teeth whitening composition and methods

Related Child Applications (3)

Application Number Title Priority Date Filing Date
PCT/CA2011/050261 Continuation WO2011134087A1 (en) 2006-11-09 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US13/643,672 Continuation US9345648B2 (en) 2005-11-09 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US201313643672A Continuation 2013-01-22 2013-01-22

Publications (1)

Publication Number Publication Date
US20100266989A1 true US20100266989A1 (en) 2010-10-21

Family

ID=44860719

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/771,105 Abandoned US20100266989A1 (en) 2005-11-09 2010-04-30 Teeth whitening compositions and methods
US13/643,672 Active US9345648B2 (en) 2005-11-09 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US15/133,536 Abandoned US20160296444A1 (en) 2005-11-09 2016-04-20 Photoactivatable oxygen-evolving compositions and methods for teeth whitening

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/643,672 Active US9345648B2 (en) 2005-11-09 2011-04-29 Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US15/133,536 Abandoned US20160296444A1 (en) 2005-11-09 2016-04-20 Photoactivatable oxygen-evolving compositions and methods for teeth whitening

Country Status (15)

Country Link
US (3) US20100266989A1 (en)
EP (2) EP3202391A1 (en)
JP (3) JP6061342B2 (en)
KR (1) KR101869109B1 (en)
CN (2) CN107049818A (en)
AU (1) AU2011245008A1 (en)
BR (1) BR112012027538B1 (en)
CA (1) CA2797867C (en)
EA (1) EA030336B1 (en)
IL (1) IL222526D0 (en)
MX (1) MX343075B (en)
NZ (2) NZ631120A (en)
SG (2) SG184945A1 (en)
WO (1) WO2011134087A1 (en)
ZA (1) ZA201208990B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110218482A1 (en) * 2008-11-07 2011-09-08 Remigio Piergallini Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US20130281913A1 (en) * 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US20130295525A1 (en) * 2010-06-15 2013-11-07 The Procter & Gamble Company Methods for whitening teeth
US8685466B2 (en) 2009-07-17 2014-04-01 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
WO2014042936A3 (en) * 2012-09-14 2014-07-24 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
US8986719B2 (en) 2005-11-09 2015-03-24 Klox Technologies Inc. Teeth whitening compositions and methods
CN104755101A (en) * 2012-09-14 2015-07-01 克洛克斯科技公司 Chromophore combinations for biophotonic uses
EP2895140A4 (en) * 2012-09-14 2016-04-06 Klox Technologies Inc Cosmetic biophotonic compositions
US9345648B2 (en) 2006-11-09 2016-05-24 Klox Technologies Inc. Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US9814576B2 (en) 2012-02-29 2017-11-14 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
US10130706B2 (en) 2013-03-14 2018-11-20 Klox Technologies Inc. Biophotonic materials and uses thereof
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10207029B2 (en) 2014-04-01 2019-02-19 Klox Technologies Inc. Tissue filler compositions and methods of use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457199B2 (en) 2014-08-08 2016-10-04 Colgate-Palmolive Company Light emitting toothbrush

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785527A (en) * 1997-01-10 1998-07-28 Ultradent Products, Inc. Stable light or heat activated dental bleaching compositions
US5858332A (en) * 1997-01-10 1999-01-12 Ultradent Products, Inc. Dental bleaching compositions with high concentrations of hydrogen peroxide
US6107466A (en) * 1996-09-19 2000-08-22 The General Hospital Corporation Acceleration of wound healing by photodynamic therapy
US6541460B2 (en) * 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6905672B2 (en) * 1999-12-08 2005-06-14 The Procter & Gamble Company Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants
US20070128132A1 (en) * 2005-11-09 2007-06-07 Remigio Piergallini Teeth whitening composition and methods
US20070166369A1 (en) * 2006-01-18 2007-07-19 Ceramoptec Industries, Inc. Photodynamic cosmetic procedure and healing method
US20110218482A1 (en) * 2008-11-07 2011-09-08 Remigio Piergallini Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

Family Cites Families (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877221A (en) 1954-03-17 1959-03-10 Pfizer & Co C 11, 14-peroxides of substituted ergostadiene compounds
US3309274A (en) * 1962-07-23 1967-03-14 Brilliant Herbert Use of fluorescent dyes in dental diagnostic methods
US3293127A (en) 1964-07-22 1966-12-20 Gold Crest Chemical Corp Inc Arterial embalming fluid and method for embalming therewith
DE1617744A1 (en) 1964-07-24 1970-09-10 Peter Strong & Co Inc Detergent for dentures
US3372125A (en) 1965-11-15 1968-03-05 Peter Strong & Company Inc Denture cleanser
US3595798A (en) * 1967-12-18 1971-07-27 Lever Brothers Ltd Cleansing compositions
US3728446A (en) 1971-01-11 1973-04-17 Colgate Palmolive Co Speckled dentifrice gel
FR2463613B1 (en) 1979-08-20 1983-01-28 Thorel Jean Noel
US4846165A (en) 1986-11-26 1989-07-11 Dentsply Research & Development Corp. Wound dressing membrane
US4574097A (en) 1984-08-10 1986-03-04 Isopedix Corporation Reinforced thixotropic gel composition
JPH059412B2 (en) 1988-04-30 1993-02-04 Kyukyu Yakuhin Kogyo Kk
US4891211A (en) 1988-06-29 1990-01-02 Church & Dwight Co., Inc. Stable hydrogen peroxide-releasing dentifice
EP0356868A3 (en) 1988-09-01 1991-03-20 Dentsply International, Inc. A method of treating a tooth with adhesive dental cavity basing composition
NL8900165A (en) 1989-01-24 1990-08-16 Matthijs Cornelis Evers Wound Powder.
CA2028136A1 (en) 1989-02-28 1990-09-29 Marc N. Benhuri Method and composition for treatment of periodontal disease
US4992256A (en) 1989-09-27 1991-02-12 Colgate-Palmolive Company Plaque disclosing compositions
DE4007428A1 (en) 1990-03-09 1991-09-12 Hoechst Ag Photopolymerisable mixt. sensitive to near UV and visible light
US5749968A (en) 1993-03-01 1998-05-12 Focal, Inc. Device for priming for improved adherence of gels to substrates
AU709527B2 (en) 1995-03-23 1999-09-02 Board Of Regents, The University Of Texas System Redox and photoinitiator systems for priming for improved adherence of gels to substrates
US5705357A (en) 1994-08-29 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Chemiluminescent reagent and assay using a substituted acetanilide for light generation
US5800373A (en) * 1995-03-23 1998-09-01 Focal, Inc. Initiator priming for improved adherence of gels to substrates
US5658148A (en) 1995-04-26 1997-08-19 Ceramoptec Industries, Inc. Dental laser brushing or cleaning device
US6056548A (en) 1995-04-26 2000-05-02 Ceramoptec Industries, Inc. Hygienic dental laser photo treatment method
AT438444T (en) 1995-09-25 2009-08-15 Discus Dental Llc compositions tooth bleaching
US5713738A (en) 1995-12-12 1998-02-03 Britesmile, Inc. Method for whitening teeth
WO1998010738A1 (en) 1996-09-16 1998-03-19 The Procter & Gamble Company Antimicrobial oral care compositions
US7390668B2 (en) 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US7353829B1 (en) 1996-10-30 2008-04-08 Provectus Devicetech, Inc. Methods and apparatus for multi-photon photo-activation of therapeutic agents
US7648695B2 (en) 1998-08-06 2010-01-19 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
WO1998023219A1 (en) 1996-11-27 1998-06-04 Sibner Jeffrey A Dental bleaching composition and method
US6846182B1 (en) 1996-11-27 2005-01-25 Jeffrey A. Sibner Dental bleaching composition and method
FR2756741B1 (en) 1996-12-05 1999-01-08 Cird Galderma Use of a chromophore in a composition intended to be applied on the skin before a laser treatment
JPH10182390A (en) 1996-12-25 1998-07-07 Lion Corp Composition for oral cavity
US6391283B1 (en) 1997-01-10 2002-05-21 Ultradent Products, Inc. Methods and apparatus for activating dental compositions
AU718619B2 (en) 1997-01-30 2000-04-20 Ciba Specialty Chemicals Holding Inc. Non-volatile phenylglyoxalic esters
US6305936B1 (en) 1997-02-19 2001-10-23 Ultradent Products, Inc. Polymerizable isolation barriers with reduced polymerization strength and methods for forming and using such barriers
DE69814501T2 (en) 1997-02-24 2004-03-25 KURARAY CO., LTD, Kurashiki Antimicrobial caries-indicating composition
US5922331A (en) 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
JPH10330235A (en) 1997-06-02 1998-12-15 Lion Corp Agent for washing artificial tooth
US6108850A (en) 1997-06-03 2000-08-29 Mclaughlin; Gerald Accelerated method and instrumentation for whitening teeth
US6079746A (en) 1997-07-21 2000-06-27 Olsen; Fred Ski conversion apparatus
JP3386989B2 (en) * 1997-11-10 2003-03-17 花王株式会社 Cosmetics
US6161544A (en) 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
US6162055A (en) 1998-02-13 2000-12-19 Britesmile, Inc. Light activated tooth whitening composition and method of using same
US20030198605A1 (en) 1998-02-13 2003-10-23 Montgomery R. Eric Light-activated tooth whitening composition and method of using same
PL343023A1 (en) 1998-02-13 2001-07-30 Britesmile Light-activated tooth whitening composition and method of using same
US5977199A (en) 1998-02-17 1999-11-02 The Kerr Corporation Composition, delivery system therefor, and method for making temporary crowns and bridges
US6149895A (en) 1998-02-17 2000-11-21 Kreativ, Inc Dental bleaching compositions, kits & methods
AU3371799A (en) 1998-03-30 1999-10-18 Fibermark, Inc. Light-activated antimicrobial polymeric materials
US6036493A (en) 1998-07-23 2000-03-14 Ad Dent Inc. Dental bleaching system and method
JP4199333B2 (en) 1998-08-07 2008-12-17 宇部マテリアルズ株式会社 Dentifrice composition
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6030222A (en) 1998-12-01 2000-02-29 Tarver; Jeanna G. Dye compositions and methods for whitening teeth using same
US6423697B1 (en) 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
US6420455B1 (en) 1999-06-18 2002-07-16 3M Innovative Properties Company Antimicrobial composition containing photosensitizers articles, and methods of use
IT1306679B1 (en) 1999-06-29 2001-10-02 Fidia Advanced Biopolymers Srl Use of hyaluronic acid derivatives for the pharmaceutical preparation dicomposizoni and biomaterials for the prevention of
US6365134B1 (en) 1999-07-07 2002-04-02 Scientific Pharmaceuticals, Inc. Process and composition for high efficacy teeth whitening
NL1012696C2 (en) 1999-07-23 2001-01-24 Berg Electronics Mfg Header or receptacle for use in a power connector.
AT406157T (en) 1999-08-13 2008-09-15 Provectus Pharmatech Inc Improved topical medications and methods for photodynamic treatment of diseases
US7220438B2 (en) 1999-09-23 2007-05-22 Asac Compañia de Biotecnologia Pharmacological activities of Curcuma longa extracts
CA2393013C (en) 1999-12-08 2007-10-30 The Procter & Gamble Company Tartar control denture adhesive compositions
US6475497B1 (en) 1999-12-08 2002-11-05 The Procter & Gamble Company Tartar control denture adhesive compositions
US6475498B1 (en) 1999-12-08 2002-11-05 The Procter & Gamble Company Method to inhibit tartar and stain using denture adhesive compositions
US6444725B1 (en) 2000-01-21 2002-09-03 3M Innovative Properties Company Color-changing dental compositions
JP5101778B2 (en) 2000-02-11 2012-12-19 ザ ジェネラル ホスピタル コーポレイション Tissue adhesion by the photochemical action
US6267976B1 (en) 2000-04-14 2001-07-31 Gojo Industries, Inc. Skin cleanser with photosensitive dye
US6800671B1 (en) 2000-04-21 2004-10-05 Britesmile, Inc. Low peak exotherm curable compositions
CA2422592A1 (en) 2000-09-14 2002-03-21 High Tech Laser Simultaneous use of laser and oxidizing composition for dental bleaching
US6528555B1 (en) 2000-10-12 2003-03-04 3M Innovative Properties Company Adhesive for use in the oral environment having color-changing capabilities
DE10056114A1 (en) 2000-11-04 2002-05-29 Wolfgang Malodobry Free scars Tattoo removal
US6485709B2 (en) 2001-01-23 2002-11-26 Addent Inc. Dental bleaching gel composition, activator system and method for activating a dental bleaching gel
US20070244195A1 (en) 2004-05-18 2007-10-18 Burkhart Craig N Treatment methods with peroxides and tertiary amines
JP2002293747A (en) 2001-03-29 2002-10-09 Jinen:Kk Skin preparation for external use
AT502657T (en) 2001-05-01 2011-04-15 Av Topchiev Inst Petrochemical Two-phase, water-absorbent bioadhesive zusammenstezung
ITMI20011315A1 (en) 2001-06-21 2002-12-23 Herbariorum Medicaminum Offici Composition for anti-plaque toothpaste with plaque detector
US6558653B2 (en) 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
US7329273B2 (en) 2001-11-29 2008-02-12 Palomar Medicaltechnologies, Inc. Tissue penetrating oral phototherapy applicator
EP1467760A2 (en) 2002-01-23 2004-10-20 Light Sciences Corporation Systems and methods for photodynamic therapy
US6960079B2 (en) 2002-04-18 2005-11-01 3M Innovative Properties Company Orthodontic adhesives and appliances including an adhesive on the base of the appliance
WO2003100261A2 (en) 2002-05-07 2003-12-04 Atair Aerospace, Inc. Pneumatic riser release
US6949240B2 (en) 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
GB0222091D0 (en) 2002-09-24 2002-10-30 Boots Co Plc Dental compositions and methods
KR20050055760A (en) 2002-10-11 2005-06-13 노보셀, 인크 Implantation of encapsulated biological materials for treating diseases
US7157502B2 (en) 2003-02-19 2007-01-02 Pulpdent Corporation Polymerizable dental barrier material
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US20040191330A1 (en) 2003-03-31 2004-09-30 Keefe Candace R. Daily skin care regimen
US7114953B1 (en) 2003-04-25 2006-10-03 Wagner Eugene C Tooth whitening appliance having membrane covered applicator
CN1835723B (en) * 2003-06-16 2011-06-22 洛马林达大学医学中心 Deployable multifunctional hemostatic agent
JP2003339875A (en) 2003-06-16 2003-12-02 Hirokatsu Kimura Tatoo eliminating device
GB0314210D0 (en) 2003-06-18 2003-07-23 Unilever Plc Laundry treatment compositions
EP2263788B1 (en) 2003-07-31 2018-07-25 Sol-Gel Technologies Ltd. A process for the preparation of microcapsules filled with active ingredients
AU2004277378A1 (en) 2003-08-01 2005-04-14 Glotell Products, Inc. Dye solution and method for detecting anhydrous ammonia
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050042712A1 (en) * 2003-08-22 2005-02-24 Advanced Medical Optics, Inc. Methods, compositions and instruments to predict antimicrobial or preservative activity
US20050049228A1 (en) 2003-09-02 2005-03-03 Ceramoptec Industries Inc. Antimicrobial photodynamic therapy compound and method of use
US20050059731A1 (en) 2003-09-16 2005-03-17 Ceramoptec Industries, Inc. Erythrosin-based antimicrobial photodynamic therapy compound and its use
WO2005051305A2 (en) 2003-11-19 2005-06-09 Barnes-Jewish Hospital Enhanced drug delivery
JP4496375B2 (en) 2004-05-21 2010-07-07 国立大学法人鳥取大学 Medicament for the treatment or the treatment of wounds
US20050281890A1 (en) 2004-06-18 2005-12-22 San Chandan K Methods and compositions for wound healing
AU2005269869B2 (en) 2004-07-08 2011-12-01 3M Innovative Properties Company Dental methods, compositions, and kits including acid-sensitive dyes
GB0420888D0 (en) 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
CA2486475A1 (en) 2004-11-02 2006-05-02 John Kennedy Method of treating microorganisms in the oral cavity
AU2005323350B2 (en) 2004-11-09 2011-04-21 Discus Dental, Llc. Two-component dental whitening compositions
KR100657127B1 (en) * 2004-11-29 2006-12-12 주식회사 엘지생활건강 Delivery system for tooth whitening component using in situ gelling
WO2006072243A1 (en) 2005-01-03 2006-07-13 Novozymes Biopolymer A/S Hyaluronic acid fraction with moisturizing and anti-wrinkle properties
WO2006089028A2 (en) 2005-02-15 2006-08-24 Lab39, Llc Foaming compositions and methods
EP1733762A1 (en) 2005-05-25 2006-12-20 3M Espe AG Dental composition for detection of carious tissue, detection method
WO2006135344A1 (en) 2005-06-13 2006-12-21 National University Of Singapore A photosensitising composition and uses thereof
CA2632183A1 (en) 2005-08-25 2007-03-01 Philip R. Houle Treatment systems for delivery of sensitizer solutions
US20070092469A1 (en) 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
EP1779891A1 (en) 2005-10-28 2007-05-02 Abdula Kurkayev Method of activating a photosensitizer
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
AR059155A1 (en) * 2006-01-23 2008-03-12 Procter & Gamble Compositions comprising enzymes and bleaches
US8454991B2 (en) 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
WO2008013962A2 (en) 2006-07-28 2008-01-31 Ceramoptec Industries, Inc. Method and mixture for in-vivo photochemical cross-linking of collagen
WO2008052081A2 (en) 2006-10-24 2008-05-02 California Institute Of Technology Photochemical therapy to affect mechanical and/or chemical properties of body tissue
CN101594904A (en) 2006-10-24 2009-12-02 加州理工学院 Photochemical therapy to affect mechanical and/or chemical properties of body tissue
US20080108681A1 (en) 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20080113037A1 (en) 2006-11-10 2008-05-15 Green Barbara A Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs
WO2008085794A2 (en) 2007-01-03 2008-07-17 Burnham Institute For Medical Research Methods and compositions related to clot binding compounds
JP5193230B2 (en) 2007-02-09 2013-05-08 クロックス テクノロジーズ インコーポレイテッド Photopolymer material for gingival isolation
EP2149360A4 (en) * 2007-05-31 2014-01-22 Tokuyama Dental Corp Adhesive for teeth-straightening members
BRPI0905679A2 (en) 2008-01-08 2015-07-07 Quick Med Technologies Inc Method to manufacture and disinfecting composition and a substrate to impart durable antimicrobial activity on a substrate
WO2009089345A2 (en) 2008-01-08 2009-07-16 Blazetrak, Llc Review managment system for audition portfolios
US20090238778A1 (en) 2008-03-19 2009-09-24 Mordas Carolyn J Tooth whitening compositions, delivery systems and methods
SG10201700310PA (en) 2009-07-17 2017-03-30 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
FR2948584B1 (en) 2009-07-30 2012-08-03 Prod Dentaires Pierre Rolland Application Tip
JP5932653B2 (en) 2009-10-27 2016-06-08 クロクス テクノロジーズ インコーポレイテッド Device for personal use in phototherapy
US20120244491A1 (en) 2011-03-22 2012-09-27 Remigio Piergallini Device and method for teeth brightening
EP3385949A1 (en) 2011-05-13 2018-10-10 Samsung Electronics Co., Ltd. Bit allocating method for encoding an audio signal spectrum
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
MX351267B (en) 2012-09-14 2017-10-06 Valeant Pharmaceuticals Int Inc Compositions and methods for teeth whitening.
JP2015528473A (en) 2012-09-14 2015-09-28 クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. Beauty biological light composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541460B2 (en) * 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6107466A (en) * 1996-09-19 2000-08-22 The General Hospital Corporation Acceleration of wound healing by photodynamic therapy
US5785527A (en) * 1997-01-10 1998-07-28 Ultradent Products, Inc. Stable light or heat activated dental bleaching compositions
US5858332A (en) * 1997-01-10 1999-01-12 Ultradent Products, Inc. Dental bleaching compositions with high concentrations of hydrogen peroxide
US6905672B2 (en) * 1999-12-08 2005-06-14 The Procter & Gamble Company Compositions and methods to inhibit tartar and microbes using denture adhesive compositions with colorants
US20070128132A1 (en) * 2005-11-09 2007-06-07 Remigio Piergallini Teeth whitening composition and methods
US20070166369A1 (en) * 2006-01-18 2007-07-19 Ceramoptec Industries, Inc. Photodynamic cosmetic procedure and healing method
US20110218482A1 (en) * 2008-11-07 2011-09-08 Remigio Piergallini Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US20110224599A1 (en) * 2008-11-07 2011-09-15 Remigio Piergallini Combination of an oxidant and a photoactivator for the healing of wounds

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986719B2 (en) 2005-11-09 2015-03-24 Klox Technologies Inc. Teeth whitening compositions and methods
US9345648B2 (en) 2006-11-09 2016-05-24 Klox Technologies Inc. Photoactivatable oxygen-evolving compositions and methods for teeth whitening
US20110218482A1 (en) * 2008-11-07 2011-09-08 Remigio Piergallini Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US9375446B2 (en) 2008-11-07 2016-06-28 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US8632822B2 (en) 2008-11-07 2014-01-21 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US8637086B2 (en) 2008-11-07 2014-01-28 Klox Technologies Inc. Method for acne treatment using an oxidative-photoactivated composition
US8658219B2 (en) 2008-11-07 2014-02-25 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US9597349B2 (en) 2008-11-07 2017-03-21 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US10149985B2 (en) 2008-11-07 2018-12-11 Klox Technologies Inc. Methods and compositions for treating rosacea
US8911791B2 (en) 2008-11-07 2014-12-16 Klox Technologies Inc. Method for acne treatment using an oxidative-photoactivated composition
US20110224599A1 (en) * 2008-11-07 2011-09-15 Remigio Piergallini Combination of an oxidant and a photoactivator for the healing of wounds
US8974833B2 (en) 2008-11-07 2015-03-10 Klox Technologies Inc. Combination of an oxidant and a photoactivator for the healing of wounds
US8986745B2 (en) 2008-11-07 2015-03-24 Klox Technologies Inc. Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US8986746B2 (en) 2009-07-17 2015-03-24 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US8685466B2 (en) 2009-07-17 2014-04-01 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US9603929B2 (en) 2009-07-17 2017-03-28 Klox Technologies Inc. Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfecton and treatment of oral disease
US9622840B2 (en) * 2010-06-15 2017-04-18 The Procter & Gamble Company Methods for whitening teeth
US20170239029A1 (en) * 2010-06-15 2017-08-24 The Procter & Gamble Company Methods for whitening teeth
US20130295525A1 (en) * 2010-06-15 2013-11-07 The Procter & Gamble Company Methods for whitening teeth
US9814576B2 (en) 2012-02-29 2017-11-14 Valcare, Inc. Methods, devices, and systems for percutaneously anchoring annuloplasty rings
RU2668127C2 (en) * 2012-04-20 2018-09-26 Клокс Текнолоджиз Инк. Biophotonic compositions, kits and methods
CN104350125A (en) * 2012-04-20 2015-02-11 克洛克斯科技公司 Biophotonic compositions, kits and methods
US20130281913A1 (en) * 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
EP2838974A4 (en) * 2012-04-20 2016-01-06 Klox Technologies Inc Biophotonic compositions, kits and methods
US10213373B2 (en) 2012-04-20 2019-02-26 Klox Technologies, Inc. Chromophore combinations for biophotonic uses
US9655829B2 (en) 2012-09-14 2017-05-23 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
EP3178467A1 (en) * 2012-09-14 2017-06-14 KLOX Technologies, Inc. Cosmetic biophotonic compositions
EP2895140A4 (en) * 2012-09-14 2016-04-06 Klox Technologies Inc Cosmetic biophotonic compositions
CN104994830A (en) * 2012-09-14 2015-10-21 威朗国际制药公司 Compositions and methods for teeth whitening
AU2013315303B2 (en) * 2012-09-14 2018-07-26 Klox Technologies Inc. Chromophore combinations for biophotonic uses
CN104755101A (en) * 2012-09-14 2015-07-01 克洛克斯科技公司 Chromophore combinations for biophotonic uses
CN104755101B (en) * 2012-09-14 2018-10-02 克洛克斯科技公司 Biophoton combination of chromophore
WO2014042936A3 (en) * 2012-09-14 2014-07-24 Valeant Pharmaceuticals International, Inc. Compositions and methods for teeth whitening
EP2895194A4 (en) * 2012-09-14 2016-03-09 Klox Technologies Inc Chromophore combinations for biophotonic uses
US10130706B2 (en) 2013-03-14 2018-11-20 Klox Technologies Inc. Biophotonic materials and uses thereof
US10166100B2 (en) 2013-03-15 2019-01-01 Valcare, Inc. Systems and methods for delivery of annuloplasty rings
US10207029B2 (en) 2014-04-01 2019-02-19 Klox Technologies Inc. Tissue filler compositions and methods of use

Also Published As

Publication number Publication date
NZ603601A (en) 2015-01-30
NZ631120A (en) 2015-12-24
EP3202391A1 (en) 2017-08-09
MX343075B (en) 2016-10-24
US20130122467A1 (en) 2013-05-16
EP2563323A1 (en) 2013-03-06
JP2013525380A (en) 2013-06-20
KR101869109B1 (en) 2018-06-19
CA2797867A1 (en) 2011-11-03
JP2016065077A (en) 2016-04-28
JP2018065844A (en) 2018-04-26
US20160296444A1 (en) 2016-10-13
SG184945A1 (en) 2012-11-29
BR112012027538A2 (en) 2017-08-08
CA2797867C (en) 2017-08-15
US9345648B2 (en) 2016-05-24
MX2012012481A (en) 2013-03-07
IL222526D0 (en) 2012-12-31
EA030336B1 (en) 2018-07-31
EP2563323A4 (en) 2015-10-21
CN102939072A (en) 2013-02-20
JP6061342B2 (en) 2017-01-18
CN107049818A (en) 2017-08-18
EA201291068A1 (en) 2013-05-30
KR20130108992A (en) 2013-10-07
AU2011245008A1 (en) 2012-12-06
BR112012027538B1 (en) 2018-04-03
WO2011134087A1 (en) 2011-11-03
SG10201503416UA (en) 2015-06-29
ZA201208990B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
Thitinanthapan et al. In vitro penetration of the pulp chamber by three brands of carbamide peroxide
US6843981B1 (en) Tooth bleaching compositions and methods of bleaching discolored tooth
AU652865B2 (en) Oral composition having improved tooth whitening effect
US5785527A (en) Stable light or heat activated dental bleaching compositions
US7128899B2 (en) Bleaching device comprising a barrier layer and a bleaching composition comprising polyvinylpyrrolidone
US5713738A (en) Method for whitening teeth
US6221341B1 (en) Tooth whitening compositions
Buchalla et al. External bleaching therapy with activation by heat, light or laser—a systematic review
US5240415A (en) Dental bleach system having separately compartmented fumed silica and hydrogen peroxide and method of using
US6958144B2 (en) Methods of whitening teeth
EP1663059B1 (en) Kit comprinsing an illuminated electric toothbrush
US6391283B1 (en) Methods and apparatus for activating dental compositions
US5302375A (en) Oral composition having improved tooth whitening effect
US5171564A (en) Aqueous tooth whitening dentifrice
US5032178A (en) Dental composition system and method for bleaching teeth
KR100545895B1 (en) Method for bleaching discolored tooth by titanium dioxide photocatalyst
US20060198795A1 (en) Multi-component oral care compositions
AM Sulieman An overview of tooth‐bleaching techniques: chemistry, safety and efficacy
Greenwall Bleaching techniques in restorative dentistry: An illustrated guide
Walsh Safety issues relating to the use of hydrogen peroxide in dentistry
Kihn Vital tooth whitening
CA2386808C (en) Apparatus for simultaneous illumination of teeth
US6365134B1 (en) Process and composition for high efficacy teeth whitening
Zhang et al. Effects of KTP laser irradiation, diode laser, and LED on tooth bleaching: a comparative study
AU2005304373B2 (en) Dental whitening systems comprising transition metal salt activator

Legal Events

Date Code Title Description
AS Assignment

Owner name: KLOX TECHNOLOGIES INC., CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PIERGALLINI, REMIGIO;LOUPIS, NIKOLAOS;SIGNING DATES FROM20101122 TO 20101129;REEL/FRAME:025669/0570